VANCOUVER, British Columbia, Feb. 20, 2020 (GLOBE NEWSWIRE) — Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) provides the following corporate update to shareholders.
Bay Street News
VANCOUVER, British Columbia, Feb. 20, 2020 (GLOBE NEWSWIRE) — Lexington Biosciences, Inc. (CSE: LNB) (the “Company” or “Lexington”) provides the following corporate update to shareholders.
Bay Street News